GRCE GRACE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Stock Splits On July 24, 2023, Acasti Pharma Inc. regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market following a one-for-six reverse split of its common shares effective on July 10, 2023.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC